Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20109171 | 0.71 | CES2 (0.31) | CES2CES1 | |
| SCHEMBL346418 | 0.63 | CES1 (0.45) | CES2CES1 | |
| Ethylene Glycol SCHEMBL10986319 | 0.62 | ALDH1A1 (0.45) | CES2CES1 | |
| SCHEMBL28546562 | 0.60 | CES1 (0.53) | CES2CES1 | |
| SCHEMBL453159 | 0.60 | CES1 (0.41) | CES2CES1 | |
| SCHEMBL10474453 | 0.60 | CES1 (0.42) | CES2CES1 | |
| SCHEMBL27912995 | 0.60 | CES1 (0.41) | CES2CES1 | |
| SCHEMBL22092201 | 0.58 | CES1 (0.46) | CES2CES1 | |
| Ammonia Solution, Strong SCHEMBL4627589 | 0.58 | CES1 (0.50) | CES2CES1 | |
| SCHEMBL4791139 | 0.57 | CES2 (0.48) | CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180118770-A1 | N-Heterocyclic Phosphines | THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118770-A1 | N-Heterocyclic Phosphines | NANP, PPIP5K2, PHPT1 | CES2 2807/4885CES1 3917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.